CSI Market
Sign In | Register

Vincerx Pharma Inc (VINC) Quarterly Cash Flow Statement

Quarterly · GAAP · USD millions
Access VINC Annual Cash Flow →
This page allows investors to follow Vincerx Pharma Inc's cash flow patterns across multiple reporting periods and assess consistency in cash generation.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Quarterly Report, GAAP in USD millions
ITEM 		(Mar 31 2025)
3 Months 		(Dec 31 2024) (Sep 30 2024) (Jun 30 2024) (Mar 31 2024)
Operating Activities
Income-5.00
Depreciation & amortization0.00
Amortization of Other Assets0.00
Extraordinary Item, Gain (Loss), Insurance Assets, Accretion Expense0.00
Restructuring & Impairment Charges0.00
Provision For Loan Losses Expensed0.00
Inventories Decrease /-Increase0.00
R & D, Environmental and Other Expense0.00
Gain (Loss) on Disposition of Assets0.00
Share-based Compensation0.44
Income (Loss) from Equity Method Investments0.00
Fair Value Adjustment of Warrants-0.01
Amortization Of Right Of Use Assets Operating Lease-
Operating Lease Right Of Use Asset Amortization Expense-
Financing Cost Derivative Warrant Liabilities-
Research And Development Asset Acquired Other Than Through Business Combination Written Off-
Amortization Of Right Of Use Assets Liabilities-
Increase Decrease In Grants Receivable1.04
Income taxes0.00
Losses/ -gains on Investments net0.00
Accounts Receivable0.00
Increase (Decrease) in Accounts Payable0.24
Increase (Decrease) in Accrued Liabilities-2.89
Deferred Revenue and Customer Advances and Deposits0.00
Increase (Decrease) in Prepaid Expense0.14
Other Working Capital-0.14
Other Noncash Income (Expense)0.00
Other net0.00
Payments for (Proceeds from) Other Operating Activities1.74
Discontinued operations0.00
Net Cash flow from Operating Activities-4.45
Investing Activities
Capital Expenditures0.00
Sale of Capital Items0.00
Proceeds from Sale and Maturity of Marketable Securities0.00
Payments to Acquire Marketable Securities0.00
Real Estate Investments0.00
Restricted Cash and Investments Increase (Decrease)0.00
Payments for (Proceeds from) Loans0.00
Payments for (Proceeds from) Deposits0.00
Payments for (Proceeds from) Other Investments0.00
Payments for (Proceeds from) Federal Reserve and FHLB0.00
Payments to Acquire in Process Research and Development0.00
Interest in Subsidiaries and Affiliates0.00
Sale of businesses0.00
Accounts payable0.00
Receivables0.00
Payments for (Proceeds from) Other Investing Activities0.00
Other Net0.00
Discontinued operations0.00
Net Cash Flow from Investing Activities0.00
Financing Activities
Short-term debt Net0.00
Other borrowing transactions0.00
Long-term debt - borrowings0.00
Long-term debt - repayments0.00
Federal Home Loan Bank and Federal Funds0.00
Issuances / -repurchases of Comm. Stock0.00
Partnership and Parent Transactions0.00
Issuances / -repurchases of Pref. Stock0.00
Deposits, Annuities, Contract Holders Funds0.00
Other financing activities net0.00
Other net-5.07
Proceeds From Sale Of Units Net Of Underwriting Discounts Paid-
Net Proceeds From Reverse Acquisition-
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents5.07
Proceeds From At The Market Offering Net Of Transaction Costs3.86
Payments of Dividends, Preferred Stock and Preference Stock0.00
Dividends paid0.00
Net Cash Flow from Financing Activities3.86
Effect of exchange rate on cash flow0.05
Discontinued operations0.00
Free Cash Flow-4.45
Total Cash Flow-0.55
4 historic quarters locked

Sign in to unlock the full Vincerx Pharma Inc cash flow history.

Sign In Create Free Account

About Vincerx Pharma Inc Quarterly Cash Flow Statement

What this statement shows

This page presents issuer-reported cash flow data, including operating, investing, financing, net, and free cash flow, as disclosed in SEC 10-Q filings and normalized by CSIMarket.

Source & verification

  • Form: 10-Q (Period: 20250331)
  • Filed with the SEC: May 15, 2025
  • Source: d903288d10q.htm

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - normalization in the CSIMarket.com database.
  • Accession: 0001193125-25-120762

Figures are derived from filed reports and may be restated. Historical data is subject to revision.